Charles River Laboratories International Inc (NYSE:CRL)
$ 178.58 -2.81 (-1.55%) Market Cap: 9.22 Bil Enterprise Value: 12.02 Bil PE Ratio: 21.34 PB Ratio: 2.48 GF Score: 91/100

Q4 2018 Charles River Laboratories International Inc Earnings Call Transcript

Feb 13, 2019 / 01:30PM GMT
Release Date Price: $139.12 (+7.68%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories' Fourth Quarter 2018 Earnings and 2019 Guidance Call. (Operator Instructions) As a reminder, today's conference is being recorded.

I would now like to turn the conference over to your host, Corporate Vice President of Investor Relations, Mr. Todd Spencer. Please go ahead.

Todd Spencer
Charles River Laboratories International, Inc. - Corporate VP of IR

Thank you. Good morning, and welcome to Charles River Laboratories' Fourth Quarter 2018 Earnings and 2019 Guidance Conference Call and Webcast. This morning, Jim Foster, Chairman, President and Chief Executive Officer; and David Smith, Executive Vice President and Chief Financial Officer, will comment on our results for the fourth quarter of 2018 and our guidance for 2019 as well as the proposed acquisition of Citoxlab. Following the presentation, they will respond to questions.

There is a slide presentation associated with today's remarks, which is posted on the Investor Relations section of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot